Raymond James & Associates’s Chimerix, Inc. CMRX Stock Holding History

Raymond James & Associates’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$12.3K	Sell	13,200 -10,000	-43%	-$8.92K	﹤0.01%	3962
2024 Q2	$20.3K	Sell	23,200 -20,000	-46%	-$19K	﹤0.01%	3890
2024 Q1	$45.8K	Hold	43,200	–	–	﹤0.01%	3812
2023 Q4	$41.6K	Sell	43,200 -6,000	-12%	-$5.81K	﹤0.01%	3723
2023 Q3	$47.2K	Sell	49,200 -10,000	-17%	-$10.9K	﹤0.01%	3679
2023 Q2	$71.6K	Sell	59,200 -5,000	-8%	-$6.34K	﹤0.01%	3674
2023 Q1	$80.9K	Buy	64,200 +18,143	+39%	+$29.6K	﹤0.01%	3684
2022 Q4	$85.7K	Buy	+46,057	New	+$90.1K	﹤0.01%	3665
2016 Q4	–	Sell	-29,900	Closed	-$166K	–	3371
2016 Q3	$166K	Buy	29,900 +2,817	+10%	+$12.9K	﹤0.01%	2903
2016 Q2	$106K	Buy	27,083 +1,757	+7%	+$8.68K	﹤0.01%	2792
2016 Q1	$129K	Buy	+25,326	New	+$165K	﹤0.01%	2674

Other funds holding CMRX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Raymond James & Associates's CMRX Position: Q3 2024 in Review

Raymond James & Associates reduced its Chimerix, Inc. (CMRX) stake by 43% in Q3 2024, selling an estimated $8.92K and leaving 13,200 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3962.

Raymond James & Associates first reported a position in CMRX in Q1 2016 and has held it in 11 quarters since. The position peaked at $166K in Q3 2016. 65 funds tracked by Wall St. Rank hold CMRX as of Q3 2024.

Raymond James & Associates held 13,200 shares of Chimerix, Inc. worth $12.3K as of Q3 2024.
Raymond James & Associates sold 10,000 Chimerix, Inc. shares in Q3 2024, an estimated $8.92K.
Chimerix, Inc. made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3962 holding.
Raymond James & Associates first reported a position in Chimerix, Inc. in Q1 2016 and has held it in 11 quarters since.
Raymond James & Associates's Chimerix, Inc. position peaked at $166K in Q3 2016.
65 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.